Hypermarcas (OTCMKTS:HYPMY – Get Free Report) saw a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 16 shares, a drop of 99.9% from the November 30th total of 11,176 shares. Based on an average daily trading volume, of 13,330 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 13,330 shares, the short-interest ratio is currently 0.0 days.
Hypermarcas Stock Performance
Shares of HYPMY stock traded up $0.28 during trading on Thursday, reaching $4.41. 1,437 shares of the company’s stock were exchanged, compared to its average volume of 22,069. Hypermarcas has a twelve month low of $2.86 and a twelve month high of $5.18. The firm’s fifty day moving average price is $4.53 and its 200-day moving average price is $4.51. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $2.79 billion, a PE ratio of 19.15 and a beta of 0.73.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%. The firm had revenue of $408.83 million during the quarter.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Featured Stories
- Five stocks we like better than Hypermarcas
- Do not delete, read immediately
- How Long Will $1M Last in Retirement?
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
